What is Relmada Therapeutics, Inc.'s share price?

Relmada Therapeutics, Inc. (RLMD) reported share price of $2.20 in Q4 2025.

What does share price mean?

The current market valuation of a single share of the company's common stock as determined by public exchange trading. It reflects investor sentiment, market expectations for future clinical trial success, and the company's overall growth prospects. This metric serves as the primary indicator of shareholder value and market capitalization.

Relmada Therapeutics, Inc. RLMD Share Price

Share Price at other companies

Hercules CapitalHTGC

$14.77-23.1%

Bain Capital Specialty FinanceBCSF

$12.40-25.3%

Prospect CapitalPSEC

$25.000.0%

TecnoglassTGLS

$0.150.0%

Center BancorpCNOB

$22.97—

Independent Bank CorporationIBCP

$32.53-6.6%

Other financials

Income statement

See full

Operating income-$19.5M-6.8%

Net income-$19.1M-8.5%

EPS (diluted)-$0.22+62.1%

Balance sheet

See full

Cash & equivalents$9.8M+750%

Total debt$104.1M-40.4%

Total equity$218.7M+875%

Total assets$235.4M+750%

Cash flow

See full

Operating cash flow-$15.1M+16.6%

Valuation

See full

Market cap$677.17M+2,907%

Returns & leverage

See full

Return on equity-48.8%-20.0pp

Debt / equity0.9×0.0×

Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SharePrice.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s share price.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s share price?: Relmada Therapeutics, Inc. (RLMD) reported share price of $2.20 in Q4 2025.
What does share price mean?: The current market valuation of a single share of the company's common stock as determined by public exchange trading. It reflects investor sentiment, market expectations for future clinical trial success, and the company's overall growth prospects. This metric serves as the primary indicator of shareholder value and market capitalization.